(2017) described a mouse model with loss‐of‐function mutations of the CTCF‐binding site at the IGF2‐H19 imprint control region, which resulted in bi‐allelic IGF2 expression and increased prevalence of prostatic intraepithelial neoplasia (PIN). This evidence concerns the gene IGF2 and prostate intraepithelial neoplasia.